NSC |
Compound |
Enrichment |
Correlation |
NSC 128687 |
6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) |
0.0278435641331422 |
-0.17806061 |
NSC 179074 |
Lead, bis[(2-cyanoethyl)cyclohexylcarbamodithioato-S,S']-, (T-4)- |
0.0278435641331422 |
-0.19895287 |
NSC 236580 |
.beta.-Alanine, N-[N-[N-[N-[1-(D-2-hydroxy-4-methyl-1-oxopentyl)-L-prolyl]-L-isoleucyl]-N-methyl-L-valyl]-N-methyl-L-alanyl]-, .rho.-lactone |
0.0278435641331422 |
-0.19013297 |
NSC 291926 |
Null |
0.0278435641331422 |
-0.19153706 |
NSC 301477 |
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- |
0.0278435641331422 |
0.024358578 |
NSC 328785 |
ANTINEOPLASTIC-328785 |
0.0278435641331422 |
-0.18500896 |
NSC 359463 |
Null |
0.0278435641331422 |
-0.33081028 |
NSC 605607 |
Null |
0.0278435641331422 |
-0.19137126 |
NSC 607088 |
Null |
0.0278435641331422 |
-0.17597081 |
NSC 610457 |
Camptothecin Derivative |
0.0278435641331422 |
0.1142969 |